Catalio Capital ManagementVenture Partner
Until Present
David Sinclair is a venture partner at Catalio Capital Management and a professor of genetics at Harvard Medical School, where he co-directs the Paul F. Glenn Labs for the Biology of Aging. He co-founded companies including Sirtris Pharmaceuticals and Life Biosciences and wrote Lifespan.
David Sinclair is a venture partner at Catalio Capital Management and a professor of genetics at Harvard Medical School, where he co-directs the Paul F. Glenn Labs for the Biology of Aging. He co-founded companies including Sirtris Pharmaceuticals and Life Biosciences and wrote Lifespan.
Until Present
Until Present